GONELLA JACQUES 4
4 · ANTARES PHARMA, INC. · Filed Jun 20, 2018
Insider Transaction Report
Form 4
GONELLA JACQUES
Director10% Owner
Transactions
- Sale
Common Stock
2018-06-15$2.95/sh−565$1,667→ 10,285,848 total
Footnotes (1)
- [F1]The sale of common stock reported in this Form 4 was made for estate planning purposes.